Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy

por Dressler, Dirk, Adib Saberi, Fereshte
Publicado 2017

Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort

por Dressler, Dirk, Adib Saberi, Fereshte
Publicado 2020

Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))

por Dressler, Dirk, Tacik, Pawel, Adib Saberi, Fereshte
Publicado 2013

Botulinum toxin dosing in arm muscles: contextual factors

por Dressler, Dirk, Kopp, Bruno, Adib Saberi, Fereshte
Publicado 2021

Botulinum toxin therapy of dystonia

por Dressler, Dirk, Adib Saberi, Fereshte, Rosales, Raymond L.
Publicado 2020

The epidemiology of dystonia: the Hannover epidemiology study

por Dressler, Dirk, Altenmüller, Eckart, Giess, Ralf, Krauss, Joachim K., Adib Saberi, Fereshte
Publicado 2022

Botulinum toxin antibody titres: measurement, interpretation, and practical recommendations

por Dressler, Dirk, Rothwell, John C., Bhatia, Kailash, Kopp, Bruno, Bigalke, Hans, Adib Saberi, Fereshte
Publicado 2022